Methods of promoting angiogenesis using cerium oxide nanoparticles

• US 8,951,539 B1
• Filed: 06/07/2012
• Issued: 02/10/2015
• Est. Priority Date: 06/07/2011
• Status: Active Grant

• Current Assignee: University of Central Florida Research Foundation Inc. (State University System of Florida)
• Original Assignee: University of Central Florida Research Foundation Inc. (State University System of Florida)
• Inventors: Das, Soumen, Self, William, Seal, Sudipta
• Primary Examiner(s): Klinkel, Kortney L
• Assistant Examiner(s): Cao, Ping
• Application Number:
  US13/490,891
• Time in Patent Office: 978 Days
• Field of Search: 424/617, 977/773, 977/915, 977/811
• US Class Current: 424/400
• CPC Class Codes: A61K 33/00 Medicinal preparations containing inorganic active ingredients
• CPC Class Codes: A61K 33/244 Lanthanides; Compounds thereof medicinal preparations containing radioactive lanthanides for use in therapy or testing in vivo A61K51/00
• CPC Class Codes: A61P 9/00 Drugs for disorders of the cardiovascular system

Abstract

Methods of using cerium oxide nanoparticles to promote angiogenesis are described. In a particular embodiment, a method of promoting angiogenesis in animal tissue comprises contacting the tissue with a composition comprising cerium oxide nanoparticles effective for stimulating proliferation of endothelial cells associated with the tissue.

Claims

1. A method of promoting angiogenesis in animal tissue, the method comprising contacting the tissue with a composition comprising cerium oxide nanoparticles effective for stimulating proliferation of endothelial cells associated with the tissue;

wherein the cerium oxide nanoparticles are spherical with a diameter of about 3 nm to about 5 nm; and

wherein the cerium oxide nanoparticles have a surface and a concentration of Ce(3+) greater than a concentration of Ce(4+) at the surface.

2. The method of claim 1, wherein the concentration of cerium oxide nanoparticles in the composition is between about 0.5 μ

M to about 1.5 μ

M.

3. The method of claim 1, wherein the concentration of cerium oxide nanoparticles in the composition is about 1 μ

M.

4. A method of promoting angiogenesis, the method comprising administering cerium oxide nanoparticles to a patient having a physiological condition that can be remediated by increasing endothelial cell proliferation;

wherein the cerium oxide nanoparticles are spherical with a diameter of about 3 nm to about 5 nm; and

wherein the cerium oxide nanoparticles have a surface and a concentration of Ce(3+) greater than a concentration of Ce(4+) at the surface.

5. The method of claim 4, wherein the cerium nanoparticles are provided in a composition at a concentration of between about 0.5 μ

M to about 1.5 μ

M.

6. The method of claim 5, wherein a concentration of cerium oxide nanoparticles in the composition is about 1 μ

M.

7. A method of promoting angiogenesis in a patient having a condition that can be remediated by increasing endothelial cell proliferation, the method comprising contacting a tissue of the patient with cerium oxide nanoparticles in an amount sufficient to transiently lower an intracellular oxygen concentration of the tissue, wherein the transient lowering the intracellular oxygen concentration stimulates expression of HIF1α

, promotes proliferation of endothelial cells, and promotes angiogenesis in the tissue;

wherein the cerium oxide nanoparticles are spherical with a diameter of about 3 nm to about 5 nm; and

wherein the cerium oxide nanoparticles have a surface and a concentration of Ce(3+) greater than a concentration of Ce(4+) at the surface.

8. The method of claim 7, wherein the cerium nanoparticles are provided in a composition at a concentration of between about 0.5 μ

M to about 1.5 μ

M.

9. The method of claim 8, wherein the concentration of cerium oxide nanoparticles in the composition is about 1 μ

M.